August 24, 2020
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds.
The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments.
Launched in late 2016, One Drop's wireless blood...
August 18, 2020
Cecelia Health, a virtual diabetes and chronic disease management startup, has raised $13 million in Series B funding. Rittenhouse Ventures and Endo Investors co-led the round, which also saw participation from Boston Millennia Partners, SustainVC, G100 Capital and others.
WHAT IT DOES
The company was initially founded as Fit4D, and focused on access to certified diabetes educators (CDE) for...
June 3, 2020
WellDoc's BlueStar chronic disease-management tool has picked up another 510(k) FDA clearance that will allow it to support adult Type 2 diabetes patients using long-acting basal insulin. The feature was announced by WellDoc this morning, but cleared by the agency in April, according to a listing on its website.
The new capability takes the form of a new program within the prescription BlueStar...
May 19, 2020
Digital chronic-disease-program company Omada Health is leaping into musculoskeletal care thanks to its acquisition of Physera, an app-based platform that includes remote consultations with physical therapists.
Although the deal was announced today, Omada said it will "immediately" begin offering the MSK program to its employer, health plan and individual customers.
“Integrating a digital...
May 7, 2020
A number of digital health companies have seen their businesses grow amid the COVID-19 crisis, and so far Livongo Health appears to be no exception. The company announced strong quarterly results headlined by revenue growth and a record number of client launches.
Taking new agreements and the prospect of continued demand for virtual services into account, the company said that it has raised its...
April 30, 2020
Chronic disease patients relying on DarioHealth's mobile glucose management system will soon have in-app access to medical specialists, thanks to a new telemedicine integration with MediOrbis' MySpecialistMD network.
According to an announcement from the companies released yesterday, the virtual services now on offer through the app include primary and acute care; chronic disease management for...
November 22, 2019
There are few clinical areas more in need of innovation than heart disease. It’s the leading killer among men and women in the US, accounting for one in every four deaths by the CDC’s numbers, and yet it’s also a body of health conditions that could be substantially mitigated through a number of lifestyle and behavior changes.
So of course it’s little surprise that cardiovascular health and care...
November 15, 2019
Livongo is touting new data regarding the efficacy of its device-and-coaching disease management platform, this time among those using its Livongo for Hypertension and Livongo for Diabetes products together.
The results, which are set to be formally presented this weekend at the American Heart Association Scientific Sessions 2019, identified significant decreases in hypertensive blood pressure as...
October 11, 2019
It’s little secret that chronic conditions are a heavy burden on the healthcare system. Diabetes, heart disease, obesity and others can stick with a patient for decades, often leading to increased spending on disease management programs and costly visits when those efforts aren’t making an impact.
What’s worse, many of the clinical advances of the past decade or so haven’t substantially moved the...
October 10, 2019
Digital chronic disease management company Omada Health has added onto June’s $73 million funding round with a new strategic investment from Intermountain Ventures. The terms of the deal were not disclosed.
WHAT THEY DO
Omada pitches its digital coaching programs as a scalable and convenient approach to chronic disease management. The company’s products address hypertension, Type 2 diabetes,...